EUVIMEDEUVIMED entdecken
Crossref

MMP2 and MMP9 are associated with the pathogenesis of recurrent pregnancy loss through protein expression rather than genetic polymorphism

Shinobu Goto, Yasuhiko Ozaki, Ryosuke Mori, Fumiko Ozawa, Yuki Obayashi, Tamao Kitaori, Mayumi Sugiura-Ogasawara

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2024.104270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Shinobu Goto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, One Kawasumi, Mizuho-ku, Aichi, Nagoya 467-8601…. Hauptthemen laut MEDLINE: Abortion, Habitual, Matrix Metalloproteinase 9, Matrix Metalloproteinase 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Matrix metalloproteinases (MMPs) degrade extracellular matrix proteins and are important for placenta formation during early pregnancy. Recurrent pregnancy loss (RPL) is associated with abnormalities in endometrial extracellular matrix remodeling. This study aimed to elucidate the roles of MMP2 and MMP9 in RPL pathogenesis. In total, 295 women with a history of RPL and 101 controls were included in this genetic study. Genotype analysis was performed using polymerase chain reaction (PCR) restriction fragment length polymorphisms. For proteolytic analysis, decidua and villi were collected from 10 RPL-miscarried women with normal fetal chromosomes (NC) and 19 women with fetal chromosome aberrations (AC). The expression of MMP2 and MMP9 in the decidua and villi was measured by IHC and ELISA. All samples were collected after obtaining informed consent. There were no statistically significant differences in MMP2-735 C/T and MMP9-1562 C/T frequencies between women with RPL and the controls. There was no significant difference in MMP2 expression levels in the villi; however, MMP9 expression was significantly higher in normal fetal chromosomes. In the decidua, the expression of MMP2 in the NC group was significantly lower, and MMP9 in the NC group was significantly higher than in the AC group. Although no differences in MMP2-735 C/T and MMP9-1562 C/T gene polymorphisms were observed in the present study, it is suggested that differences at the protein level are involved in the pathogenesis of RPL since MMP expression is not only regulated by genes but also by local inflammation and various inductive signals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualMatrix Metalloproteinase 9Matrix Metalloproteinase 2HumansFemalePregnancyAdultPolymorphism, Single NucleotideDeciduaGenotypeGenetic Predisposition to Disease

Stichwörter der Autor:innen

Decidual tissueMMPsProteolysisRecurrent pregnancy lossSNPs

Substanzen

Matrix Metalloproteinase 9Matrix Metalloproteinase 2MMP9 protein, humanMMP2 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, One Kawasumi, Mizuho-ku, Aichi, Nagoya 467-8601, Japan. Electronic address: sgoto@med.nagoya-cu.ac.jp.
  • Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, One Kawasumi, Mizuho-ku, Aichi, Nagoya 467-8601, Japan; Department of Obstetrics and Gynecology, Nagoya City Universi…
  • Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, One Kawasumi, Mizuho-ku, Aichi, Nagoya 467-8601, Japan; Department of Obstetrics and Gynecology, Toyokawa City Hospit…
  • Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical Sciences, One Kawasumi, Mizuho-ku, Aichi, Nagoya 467-8601, Japan.
  • Obayashi Maternity Clinic, 50 Shikata Michishita, Aichi, Kitanagoya City 481-0004, Japan.

Zitieren

APA

Goto, S., Ozaki, Y., Mori, R., Ozawa, F., Obayashi, Y., Kitaori, T., & Sugiura-Ogasawara, M. (2024). MMP2 and MMP9 are associated with the pathogenesis of recurrent pregnancy loss through protein expression rather than genetic polymorphism. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104270

Vancouver

Goto S, Ozaki Y, Mori R, Ozawa F, Obayashi Y, Kitaori T, et al. MMP2 and MMP9 are associated with the pathogenesis of recurrent pregnancy loss through protein expression rather than genetic polymorphism. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104270

BibTeX
@article{Goto2024,
  author = {Goto, Shinobu and Ozaki, Yasuhiko and Mori, Ryosuke and Ozawa, Fumiko and Obayashi, Yuki and Kitaori, Tamao and Sugiura-Ogasawara, Mayumi},
  title = {MMP2 and MMP9 are associated with the pathogenesis of recurrent pregnancy loss through protein expression rather than genetic polymorphism},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2024.104270}
}
Kostenlos starten →